Carlisle Companies Incorporated (CSL)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 767,400 736,100 725,200 832,100 924,000 877,900 765,300 563,100 421,700 374,200 334,400 310,500 320,100 342,100 377,700 455,200 472,800 458,300 420,100 380,900
Total stockholders’ equity US$ in thousands 2,829,000 2,923,800 3,032,000 3,058,300 3,024,400 3,041,700 2,875,100 2,678,600 2,629,500 2,544,800 2,417,900 2,411,800 2,537,700 2,475,300 2,516,200 2,518,500 2,642,800 2,681,000 2,583,200 2,524,700
ROE 27.13% 25.18% 23.92% 27.21% 30.55% 28.86% 26.62% 21.02% 16.04% 14.70% 13.83% 12.87% 12.61% 13.82% 15.01% 18.07% 17.89% 17.09% 16.26% 15.09%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $767,400K ÷ $2,829,000K
= 27.13%

To analyze Carlisle Companies Inc.'s return on equity (ROE) over the given quarters, we observe fluctuations in the ROE percentage. The trend indicates variability in the company's ability to generate profits from shareholders' equity.

In Q4 2023, the ROE stands at 27.13%, showing a slight decrease from the previous quarter's 25.18% in Q3 2023. This suggests that the company's profitability relative to its equity has improved marginally. Comparing Q4 2023 to the same period in the prior year (Q4 2022), there has been a noticeable decrease from 30.55% to 27.13%.

Across the quarters in 2023, the ROE has fluctuated within a range of 23.92% to 27.21%. This indicates some variability in the company's profitability performance throughout the year.

Looking at the trend over the past eight quarters, the ROE has shown some volatility, reaching a peak of 30.55% in Q4 2022 and a trough of 21.02% in Q1 2022. This variability may suggest changes in the company's financial leverage, asset utilization, or net profit margin over time.

Overall, while Carlisle Companies Inc. has maintained relatively strong ROE figures above 20% in most quarters, the fluctuations in the percentages indicate a degree of inconsistency in the company's ability to generate profits from shareholders' equity. Further analysis of the company's financial statements and performance drivers would be beneficial for a more in-depth understanding of its ROE dynamics.


Peer comparison

Dec 31, 2023

Company name
Symbol
ROE
Carlisle Companies Incorporated
CSL
27.13%
West Pharmaceutical Services Inc
WST
20.60%